Using health and demographic surveillance systems for teratovigilance in Africa

dc.contributor.author	Kirakoya‐Samadoulougou, Fati
dc.date.accessioned	2026-10-19T22:31:16Z
dc.date.issued	2016-11-15
dc.description.abstract	Increased funding in the past decade has improved healthcare coverage of the population and access to vaccines and drugs across sub-Saharan Africa.1 However, there is still a need to collect valid and sufficient baseline data, data on the safety of drugs and vaccines used during pregnancy, and for innovative approaches to pharmacovigilance in pregnancy to inform policy makers and to improve treatment guidelines.
dc.identifier.citation	Kirakoya‐Samadoulougou, F., Sombié, I., Ogutu, B., Tinto, H., Kouanda, S., Tiono, A. B., Otieno, W., Dodoo, A., Kamanda, M., & Sankoh, O. (2016). Using health and demographic surveillance systems for teratovigilance in Africa. The Lancet Global Health, 4(12), e906. https://doi.org/10.1016/s2214-109x(16)30252-2
dc.identifier.doi	10.1016/s2214-109x(16)30252-2
dc.identifier.uri	https://doi.org/10.1016/s2214-109x(16)30252-2
dc.identifier.uri	https://dspace.njala.edu.sl/handle/20.500.144402/1754
dc.language.iso	en
dc.publisher	Elsevier BV
dc.relation.ispartof	The Lancet Global Health
dc.rights	CC BY-NC-ND
dc.subject	health and demographic surveillance system
dc.title	Using health and demographic surveillance systems for teratovigilance in Africa
dc.type	Article

Files

Now showing 1 - 1 of 1